The evolving use of serum free light chain assays in haematology (Q34758218)

4 August 2017

1 reference

title

The evolving use of serum free light chain assays in haematology (English)

1 reference

4 August 2017

Guy Pratt

1

1 reference

4 August 2017

language of work or name

English

0 references

publication date

3 March 2008

1 reference

British Journal of Haematology

4 August 2017

published in

1 reference

4 August 2017

volume

141

1 reference

4 August 2017

issue

4

1 reference

4 August 2017

page(s)

413-422

1 reference

Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies?

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Serum test for assessment of patients with Bence Jones myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Diagnosis and monitoring a case of light-chain deposition disease in the kidney using a new, sensitive immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Immunoglobulin free light chains and solitary plasmacytoma of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventional-dose chemotherapy in Medical Research Council UK multiple myeloma trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Magnitude of response with myeloma frontline therapy does not predict outcome: importance of time to progression in southwest oncology group chemotherapy trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

International uniform response criteria for multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective well tolerated initial therapy for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Assessment of free light chains in the cerebrospinal fluid of patients with lymphomatous meningitis - a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Serum free light chains: an alternative to the urine Bence Jones proteins screening test for monoclonal gammopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Serum-free light chain-a new biomarker for patients with B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Serum free light chains for monitoring multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Schistosoma mansoni infection in eosinophil lineage-ablated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Early response to therapy and survival in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Guidelines on the diagnosis and management of multiple myeloma 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

METABOLISM OF BENCE JONES PROTEINS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

The role of the kidney in the catabolism of Bence Jones proteins and immunoglobulin fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Prognostic significance of metallothionein in B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

Prognostic Value of Circulating Plasma Cells in Monoclonal Gammopathy of Undetermined Significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2008.07079.X

10.1111/J.1365-2141.2008.07079.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference